Sino Medical's coronary artery spinous balloon dilatation catheter has been approved by the Ministry of Health of Vietnam. The product is used to dilate coronary artery stenosis. This overseas registration approval is an important part of the company's overseas business expansion and will promote overseas sales of the product. In the first quarter of 2026, Sino Medical achieved revenue of 140 million yuan and a net profit attributable to the parent company of 24.46 million yuan.
Sino Medical Sciences Technology InReceived regulatory approval in Vietnam for its coronary artery spinous balloon dilatation catheter, enabling overseas sales.